Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie
|
May 29, 2014
Retained fetal adrenal cortex in a cynomolgus macaque (Macaca fascicularis)
Zaher Radi, Mark Evans
The Journal of Toxicological Sciences
|
January 6, 2022
Development challenges for carcinogenicity risk assessments of topical drugs
Brett D Hollingshead, Nasir Khan, Maik Schuler, et al.
Toxicology and Applied Pharmacology
|
October 22, 2013
Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma
Zaher Radi, Phillip Bartholomew, Michael Elwell, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
August 21, 2010
Development and characterization of a JAK-2-specific antibody suitable for immunohistochemical investigative studies
Zaher Radi, Mathialagan Nagappan, Xiaoying Huang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 25, 2019
Kidney Cortical Transporter Expression across Species Using Quantitative Proteomics
Abdul Basit, Zaher Radi, Vishal S Vaidya, et al.
Toxicologic Pathology
|
September 3, 2016
Fecal Lipocalin-2 as a Sensitive and Noninvasive Biomarker in the TNBS Crohn's Inflammatory Bowel Disease Model
Heidi Hsieh, Jeffrey Morin, Cyndi Filliettaz, et al.
Toxicologic Pathology
|
August 23, 2013
Regulatory Forum commentary: alternative mouse models for future cancer risk assessment
Daniel Morton, Frank D Sistare, Prashant R Nambiar, et al.
Toxicologic Pathology
|
June 23, 2017
Polyomavirus-associated Prostatitis in Wistar Han Rats Following Immunosuppression in a Chronic Toxicity Study
Katherine Masek-Hammerman, Thomas P Brown, Walter F Bobrowski, et al.
Therapeutic Advances in Musculoskeletal Disease
|
January 5, 2023
Fracture in clinical studies of tofacitinib in rheumatoid arthritis
Karen E Hansen, Mahta Mortezavi, Edward Nagy, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 2, 2020
Comparative nonclinical assessments of the biosimilar PF-06410293 and originator adalimumab
Mazin Derzi, Ahmed M Shoieb, Sharon L Ripp, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie
|
May 29, 2014
Retained fetal adrenal cortex in a cynomolgus macaque (Macaca fascicularis)
Zaher Radi, Mark Evans
The Journal of Toxicological Sciences
|
January 6, 2022
Development challenges for carcinogenicity risk assessments of topical drugs
Brett D Hollingshead, Nasir Khan, Maik Schuler, et al.
Toxicology and Applied Pharmacology
|
October 22, 2013
Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma
Zaher Radi, Phillip Bartholomew, Michael Elwell, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
August 21, 2010
Development and characterization of a JAK-2-specific antibody suitable for immunohistochemical investigative studies
Zaher Radi, Mathialagan Nagappan, Xiaoying Huang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 25, 2019
Kidney Cortical Transporter Expression across Species Using Quantitative Proteomics
Abdul Basit, Zaher Radi, Vishal S Vaidya, et al.
Toxicologic Pathology
|
September 3, 2016
Fecal Lipocalin-2 as a Sensitive and Noninvasive Biomarker in the TNBS Crohn's Inflammatory Bowel Disease Model
Heidi Hsieh, Jeffrey Morin, Cyndi Filliettaz, et al.
Toxicologic Pathology
|
August 23, 2013
Regulatory Forum commentary: alternative mouse models for future cancer risk assessment
Daniel Morton, Frank D Sistare, Prashant R Nambiar, et al.
Toxicologic Pathology
|
June 23, 2017
Polyomavirus-associated Prostatitis in Wistar Han Rats Following Immunosuppression in a Chronic Toxicity Study
Katherine Masek-Hammerman, Thomas P Brown, Walter F Bobrowski, et al.
Therapeutic Advances in Musculoskeletal Disease
|
January 5, 2023
Fracture in clinical studies of tofacitinib in rheumatoid arthritis
Karen E Hansen, Mahta Mortezavi, Edward Nagy, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 2, 2020
Comparative nonclinical assessments of the biosimilar PF-06410293 and originator adalimumab
Mazin Derzi, Ahmed M Shoieb, Sharon L Ripp, et al.
Page
of 2